Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 4
2008 6
2009 4
2010 7
2011 1
2013 1
2014 3
2015 14
2016 10
2017 7
2018 2
2019 2
2020 4
2021 5
2022 4
2023 3
2024 6
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial.
Saad F, Vjaters E, Shore N, Olmos D, Xing N, Pereira de Santana Gomes AJ, Cesar de Andrade Mota A, Salman P, Jievaltas M, Ulys A, Jakubovskis M, Kopyltsov E, Han W, Nevalaita L, Testa I, Le Berre MA, Kuss I, Haresh KP; ARANOTE Study Investigators. Saad F, et al. J Clin Oncol. 2024 Dec 20;42(36):4271-4281. doi: 10.1200/JCO-24-01798. Epub 2024 Sep 16. J Clin Oncol. 2024. PMID: 39279580 Free PMC article. Clinical Trial.
A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC).
Arora A, Seenu V, Parshad R, Bansal VK, Dhar A, Mathur S, Tanwar P, Mishra P, Kataria K, Suhani, Gogia A, Kumar B, Haresh KP, Mallick S, Saini SK, Mishra A, Bansal B, Sharma J, Saikia J, Rangarajan K, Dhamija E, Prasad CP, Shamin SA, Agastm S, Kalra K, Vishvam D, Mani K, Kumar A, Bakhshi S, Batra A. Arora A, et al. Trials. 2025 Feb 27;26(1):73. doi: 10.1186/s13063-025-08726-9. Trials. 2025. PMID: 40011935 Free PMC article.
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer.
Saad F, Briganti A, Haresh KP, Vjaters E, Olmos D, Littleton N, Testa I, Srinivasan S, Verholen F, Shore N. Saad F, et al. Eur Urol Oncol. 2025 Aug 21:S2588-9311(25)00189-0. doi: 10.1016/j.euo.2025.06.010. Online ahead of print. Eur Urol Oncol. 2025. PMID: 40846621 Free article.
81 results